CIK 0000014272
- Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 220790350
- Phone
- +1 609-252-4621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-31 | Paliwal Dinesh C Director | Grant or award · Deferred Share Units | +624.7 | $62.03 | $39K | 39,801.89 |
| 2020-12-31 | Haller Julia A Director | Grant or award · Deferred Share Units | +523.94 | $62.03 | $32K | 6,072.75 |
| 2020-12-31 | Emmens Matthew Director | Grant or award · Deferred Share Units | +584.4 | $62.03 | $36K | 23,187.89 |
| 2020-12-31 | BONNEY MICHAEL W Director | Grant or award · Deferred Share Units | +372 | $62.03 | $23K | 5,467.51 |
| 2020-12-31 | BERTOLINI ROBERT J Director | Grant or award · Deferred Share Units | +564.24 | $62.03 | $35K | 22,859.84 |
| 2020-12-31 | Arduini Peter J Director | Grant or award · Deferred Share Units | +584.4 | $62.03 | $36K | 28,260.66 |
| 2020-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Exercise or conversion | +8,792 | 46,714 | ||
| 2020-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Shares withheld for taxes | −4,506 | $62.18 | $280K | 42,208 |
| 2020-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Exercise or conversion · Restricted Stock Units | −8,792 | 26,376 | ||
| 2020-12-02 | AHMED NADIM EVP and President, Hematology | Exercise or conversion | +6,594 | 34,983 | ||
| 2020-12-02 | AHMED NADIM EVP and President, Hematology | Shares withheld for taxes | −3,380 | $62.18 | $210K | 31,603 |
| 2020-12-02 | AHMED NADIM EVP and President, Hematology | Exercise or conversion · Restricted Stock Units | −6,594 | 19,782 | ||
| 2020-12-02 | Elkins David V EVP, Chief Financial Officer | Exercise or conversion | +8,792 | 63,574 | ||
| 2020-12-02 | Elkins David V EVP, Chief Financial Officer | Shares withheld for taxes | −5,087 | $62.18 | $316K | 58,487 |
| 2020-12-02 | Elkins David V EVP, Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −8,792 | 26,376 | ||
| 2020-12-02 | BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer | Exercise or conversion | +2,637 | 23,670 | ||
| 2020-12-02 | BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer | Shares withheld for taxes | −1,299 | $62.18 | $81K | 22,371 |
| 2020-12-02 | BOERNER CHRISTOPHER S. EVP, Chief Commercial Officer | Exercise or conversion · Restricted Stock Units | −2,637 | 7,913 | ||
| 2020-12-01 | Eid Joseph SVP,Head Glob. Medical Affairs | Exercise or conversion | +2,825 | 5,359 | ||
| 2020-12-01 | Eid Joseph SVP,Head Glob. Medical Affairs | Shares withheld for taxes | −968 | $62.41 | $60K | 4,391 |
Page 86 of 90 · 1,795 trades